• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病(AD)患者中强化认知康复与多奈哌齐联合治疗。

Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD).

机构信息

Alzheimer Center, Division of Geriatrics, Ospedale Ingrassia, ASP di Palermo, Palermo, Via La Loggia 5, 90100 Palermo, Italy.

出版信息

Arch Gerontol Geriatr. 2010 Nov-Dec;51(3):245-9. doi: 10.1016/j.archger.2009.11.008. Epub 2009 Dec 7.

DOI:10.1016/j.archger.2009.11.008
PMID:19969381
Abstract

Acetylcholinesterase inhibitors (AchEIs) are extensively used in Alzheimer's disease (AD) while reality orientation therapy (ROT) is a cognitive rehabilitation indicated for mentally deteriorated patients. We aimed to evaluate the efficacy of the combination of donepezil with an intensive ROT with active participation of the caregiver. Patients with AD (n=100, mean age 78.4±4.3 years) initiated treatment with donepezil, 5mg/day; 62 of them underwent a 3-week, daily ROT and physical reactivation training with the caregiver (Group A); 38 participants received only donepezil therapy (Group B). All subjects were tested for cognitive and functional abilities at baseline, at the end of the training program, and after 2 months of follow-up. There was a significant improvement in mini-mental state examination (MMSE) score (p<0.001) and the AD assessment scale-cognitive (ADAS-Cog) subscale (p<0.001), without changes in impaired activity of daily living (ADL) and instrumental ADL (IADL) after intensive ROT training in Group A. MMSE was maintained after 2 months in-home ROT continuation. There were no significant changes in MMSE in drug-only treated patients (Group B) after 3 weeks, with a non-significant tendency to improvement in ADAS-Cog. Our results suggest benefit of an intensive ROT program in dementia patients receiving donepezil that seems to be maintained as far as ROT is continued by the caregiver.

摘要

乙酰胆碱酯酶抑制剂(AchEIs)在阿尔茨海默病(AD)中广泛应用,而现实定向疗法(ROT)是一种针对精神衰退患者的认知康复疗法。我们旨在评估多奈哌齐联合强化 ROT 治疗并由照料者积极参与的疗效。100 例 AD 患者(平均年龄 78.4±4.3 岁)接受多奈哌齐治疗,起始剂量为 5mg/天;其中 62 例接受为期 3 周的每日 ROT 治疗和与照料者一起进行的身体康复训练(A 组);38 例仅接受多奈哌齐治疗(B 组)。所有受试者在基线、训练计划结束时和随访 2 个月时进行认知和功能能力测试。A 组患者在接受强化 ROT 训练后,简易精神状态检查(MMSE)评分(p<0.001)和 AD 评估量表认知分量表(ADAS-Cog)(p<0.001)显著改善,而日常生活活动能力(ADL)和工具性日常生活活动能力(IADL)无变化。在家庭 ROT 延续 2 个月后,MMSE 保持不变。在仅接受药物治疗的患者(B 组)中,在 3 周后,MMSE 没有显著变化,ADAS-Cog 有改善的趋势但不显著。我们的结果表明,在接受多奈哌齐治疗的痴呆患者中,强化 ROT 方案有益,而且只要照料者继续进行 ROT,其效果似乎可以维持。

相似文献

1
Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD).阿尔茨海默病(AD)患者中强化认知康复与多奈哌齐联合治疗。
Arch Gerontol Geriatr. 2010 Nov-Dec;51(3):245-9. doi: 10.1016/j.archger.2009.11.008. Epub 2009 Dec 7.
2
A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.一项在养老院环境中进行的关于多奈哌齐治疗阿尔茨海默病患者疗效和安全性的随机、双盲、安慰剂对照研究。
J Am Geriatr Soc. 2001 Dec;49(12):1590-9.
3
One-year treatment of Alzheimer's disease with acetylcholinesterase inhibitors: improvement on ADAS-cog and TMT A, no change or worsening on other tests.使用乙酰胆碱酯酶抑制剂对阿尔茨海默病进行一年治疗:阿尔茨海默病评估量表认知部分(ADAS-cog)和连线测验A(TMT A)有所改善,其他测试无变化或恶化。
Hum Psychopharmacol. 2005 Aug;20(6):409-14. doi: 10.1002/hup.702.
4
Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.多奈哌齐治疗重度阿尔茨海默病患者的疗效和安全性:一项随机、安慰剂对照试验的亚组分析
Int J Geriatr Psychiatry. 2005 Jun;20(6):559-69. doi: 10.1002/gps.1325.
5
An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting.一项在现实环境中进行的关于卡巴拉汀、多奈哌齐和加兰他敏的开放标签对比研究。
Curr Med Res Opin. 2004 Nov;20(11):1747-52. doi: 10.1185/030079904X6273.
6
The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.ASCOMALVA 试验:胆碱酯酶抑制剂多奈哌齐与胆碱能前体阿法丝氨酸在伴有脑血管损伤的阿尔茨海默病中的相关性:中期结果。
J Neurol Sci. 2012 Nov 15;322(1-2):96-101. doi: 10.1016/j.jns.2012.07.003. Epub 2012 Sep 7.
7
A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease.一项比较多奈哌齐和加兰他敏对轻至中度阿尔茨海默病患者疗效的跨国、随机、为期12周的研究。
Int J Geriatr Psychiatry. 2004 Jan;19(1):58-67. doi: 10.1002/gps.1038.
8
Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.多奈哌齐治疗阿尔茨海默病:常规临床环境中治疗3年后的预期情况
Dement Geriatr Cogn Disord. 2007;23(3):150-60. doi: 10.1159/000098052. Epub 2006 Dec 18.
9
The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.阿托伐他汀/多奈哌齐治疗阿尔茨海默病研究(LEADe):设计与基线特征
Alzheimers Dement. 2008 Mar;4(2):145-53. doi: 10.1016/j.jalz.2008.02.001.
10
Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study.胆碱酯酶抑制剂在老年阿尔茨海默病患者中的有效性和安全性:一项“真实世界”研究。
Arch Gerontol Geriatr Suppl. 2004(9):297-307. doi: 10.1016/j.archger.2004.04.040.

引用本文的文献

1
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis.认知刺激、认知训练和认知康复对痴呆症患者的疗效:一项系统评价和荟萃分析。
Geroscience. 2025 Feb;47(1):409-444. doi: 10.1007/s11357-024-01400-z. Epub 2024 Nov 1.
2
The effect of combination pretreatment of donepezil and environmental enrichment on memory deficits in amyloid-beta-induced Alzheimer-like rat model.多奈哌齐与环境富集联合预处理对β-淀粉样蛋白诱导的阿尔茨海默病样大鼠模型记忆缺陷的影响。
Biochem Biophys Rep. 2022 Nov 23;32:101392. doi: 10.1016/j.bbrep.2022.101392. eCollection 2022 Dec.
3
Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer's disease.
乙酰胆碱酯酶抑制剂与认知刺激联合或单独用于治疗轻度阿尔茨海默病患者。
Aging Clin Exp Res. 2021 Nov;33(11):3039-3045. doi: 10.1007/s40520-021-01837-8. Epub 2021 Mar 24.
4
Cognitive training for people with mild to moderate dementia.针对轻度至中度痴呆症患者的认知训练。
Cochrane Database Syst Rev. 2019 Mar 25;3(3):CD013069. doi: 10.1002/14651858.CD013069.pub2.
5
A comprehensive approach to reablement in dementia.痴呆康复的综合方法。
Alzheimers Dement (N Y). 2017 Jul 27;3(3):450-458. doi: 10.1016/j.trci.2017.06.005. eCollection 2017 Sep.
6
Technology-Aided Programs to Support Positive Verbal and Physical Engagement in Persons with Moderate or Severe Alzheimer's Disease.技术辅助项目,以支持中度或重度阿尔茨海默病患者进行积极的言语和身体互动。
Front Aging Neurosci. 2016 Apr 21;8:87. doi: 10.3389/fnagi.2016.00087. eCollection 2016.
7
Patients with moderate Alzheimer's disease engage in verbal reminiscence with the support of a computer-aided program: a pilot study.中度阿尔茨海默病患者在计算机辅助程序的支持下进行言语回忆:一项试点研究。
Front Aging Neurosci. 2015 Jun 3;7:109. doi: 10.3389/fnagi.2015.00109. eCollection 2015.
8
Donepezil can improve daily activities and promote rehabilitation for severe Alzheimer's patients in long-term care health facilities.多奈哌齐可改善长期护理保健机构中重度阿尔茨海默病患者的日常活动并促进康复。
BMC Neurol. 2014 Dec 17;14:243. doi: 10.1186/s12883-014-0243-7.
9
Methodological considerations regarding cognitive interventions in dementia.关于痴呆症认知干预的方法学考量
Front Aging Neurosci. 2014 Aug 13;6:212. doi: 10.3389/fnagi.2014.00212. eCollection 2014.
10
Cognitive reserve and Alzheimer's disease.认知储备与阿尔茨海默病。
Mol Neurobiol. 2015 Feb;51(1):187-208. doi: 10.1007/s12035-014-8720-y. Epub 2014 May 4.